Clinical Trials Logo

Fasciitis clinical trials

View clinical trials related to Fasciitis.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT06116799 Terminated - Plantar Fasciitis Clinical Trials

Managing Pain in Patients With Plantar Fasciitis - A Blinded Randomized Controlled Trial

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

Plantar fasciitis (PF), a leading cause of persistent heel pain, results in almost a million physician visits annually. Conservative treatment is often the first line of management with insoles being frequently prescribed. While multiple studies have compared insoles based on the degree of customization to foot contour, the literature is lacking in data comparing insoles based on their material. In this randomized clinical trial, we compared the early effects of polyethylene (PE), polyurethane (PU), and carbon fiber insoles in the treatment of PF, using a set of patient-reported outcomes.

NCT ID: NCT04111497 Terminated - Clinical trials for Chronic Graft Versus Host Disease

Glasdegib for Chronic Graft-Versus-Host Disease

Start date: December 3, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial studies whether glasdegib is helpful in treating sclerosis associated with chronic graft-versus-host disease. It will also investigate the safety of glasdegib in treating patients with chronic graft-versus-host disease.

NCT ID: NCT02973269 Terminated - Plantar Fasciitis Clinical Trials

DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis

Start date: November 14, 2016
Phase: Phase 2
Study type: Interventional

The specific aim of the study is to compare the safety and efficacy of a single administration of DaxibotulinumtoxinA for Injection versus placebo for managing plantar fasciitis.

NCT ID: NCT02624635 Terminated - Plantar Fasciitis Clinical Trials

Hip Strengthening and Manual Therapy for Heel Pain Patients

Start date: January 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effects of manual therapy and of manual therapy associated with hip strengthening in the recovery of patients with heel pain. Heel pain decreases function, balance, walking and can cause change in the movement pattern. This alterations can induce a deficit in motor control of other structures as knee and hip. There is an importance to compare the effects of manual therapy and manual therapy associated with hip strengthening on the recover of patients with heel pain.

NCT ID: NCT01996111 Terminated - Plantar Fasciitis Clinical Trials

Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis

dHACM
Start date: September 2013
Phase: N/A
Study type: Interventional

This is a prospective, controlled, randomized, blinded and comparative, single-center clinical trial comparing the improvement of patients with recalcitrant plantar fasciitis symptoms that have received standard of care versus treatment with differing amounts of injectable dehydrated human amnion/chorion membrane micrografts(dHACM).

NCT ID: NCT01588730 Terminated - Plantar Fasciitis Clinical Trials

Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy

Start date: June 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the Ankle Dorsiflexion Dynasplint System (DS) to static night splint for the reduction of pain from Plantar Fasciitis (Fasciopathy).

NCT ID: NCT00527748 Terminated - Plantar Fasciitis Clinical Trials

Foot and Ankle Range of Motion (Stretching) Apparatus

Start date: September 2007
Phase: N/A
Study type: Interventional

Range of motion at ankle joint and subtalar joint will be assessed before and after utilization of ARM device. The changes in range of motion will be recorded and compared to literature.

NCT ID: NCT00353275 Terminated - Clinical trials for Necrotizing Fasciitis

Hyperglycemia in Surgical Infections

Start date: August 2009
Phase: N/A
Study type: Interventional

The primary purpose of this study is to evaluate two glycemic control regimens on clinical outcome in patients with necrotizing soft tissue infections. Secondary aim is to evaluate the inflammatory and immune responses to the glycemic control regimens.